HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 27 filers reported holding HORIZON PHARMA INVT LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,427,000 | – | 8,805,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 144,832,000 | $191,529,000 | 6.11% |
| SYMPHONY ASSET MANAGEMENT LLC | 10,000,000 | $13,256,000 | 2.93% |
| Nicholas Investment Partners, LP | 4,380,000 | $5,784,000 | 0.60% |
| Sonora Investment Management, LLC | 4,725,000 | $6,258,000 | 0.59% |
| CSS LLC/IL | 7,836,000 | $10,420,000 | 0.58% |
| SSI INVESTMENT MANAGEMENT LLC | 6,397,000 | $8,448,000 | 0.56% |
| Shaolin Capital Management LLC | 2,500,000 | $3,323,000 | 0.54% |
| MIZUHO SECURITIES USA LLC | 5,000,000 | $6,635,000 | 0.33% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,846,000 | $11,766,000 | 0.23% |
| M&G INVESTMENT MANAGEMENT LTD | 19,210,000 | $25,357,000 | 0.22% |